Dose-Escalation Study of SCD-101 in Sickle Cell Disease
Clinical trial NCT02380079 · UNKNOWN
Trial details
- NCT number
- NCT02380079
- Sponsor
- Invenux, LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2023-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.